# US 2008/0306252 A1 · Sulfonamido ether substituted imidazoquinolines

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306252 A1
- Document ID: US20080306252A1
- Status: Published application
- Kind: A1
- Application number: 12/131,023
- Filed: 2008-05-30
- Published: 2008-12-11
- Earliest claimed: 2000-12-08
- Assignees: Coley Pharmaceutical Group, Inc.
- Inventors: Stephen L. Crooks; George W. Griesgraber; Philip D. Heppner; Bryon A. Merrill; Ralph R. Roberts; Ai-Ping Wei
- Web page: https://patentgrep.com/patent/US20080306252A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61P 31/12: Antivirals
- A61P 37/02: Immunomodulators
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.

## Claims

### Claim at position 1

-26. (canceled)

### Claim 27

A compound selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
